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ABSTRACT 
 
Aims: To synthesize small molecule alkylating compounds and analyze the kinetics of the 
alkylation in aqueous solution. Determine molecular properties and the drug likeness of these four 
compounds as potential antineoplastic agents and apply statistical analysis to identify 
interrelationships of properties.  
Study Design: Four compounds were synthesized, characterized, and studied for alkylation 
capability. The alkylation kinetics were elucidated, as well as drug likeness properties.  The 
interrelationships of properties were examined by statistical methodology.   
Place and Duration of Study: Department of Chemistry, Durham Science Center, University of 
Nebraska at Omaha, Omaha NE, from May 2015 to June 2015. 
Methodology: Four compounds were modified by the covalent bonding of an alkyl halide 
substituent or nitrogen mustard group. The four compounds were placed in aqueous solution at pH 
7.4 and 37°C to monitor alkylation efficiency that targeted p-chloroaniline. Alkylation was monitored 
utilizing fluorescamine and measurement at 400 nm. Time and absorbance plots determined 
whether alkylation step is first-order or second-order. Molecular properties Log P, formula weight, 
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polar surface area, etc., were determined. Statistical analysis and path analysis revealed which 
molecular property was most responsible for rate constant values. 
Results: Compounds A, B, C, and D showed ranges of Log P, formula weight, and polar surface 
area of 0.010 to 4.21, 177.59 to 714.77, and 29.64 to 88.63, respectively. All compounds showed a 
favorable drug likeness, with only compound C showing a violation of the Rule of 5. The Log P 
values and number of alkylation reactive sites were most responsible for rate constant value.  
Conclusion: Small molecule alkylating agents are synthesized, the efficiency of alkylation 
measured in aqueous solution utilizing fluorescamine at pH 7.4 and 37°C. Rate-order of reactions 
is determined utilizing fluorescamine assay for surviving primary amine groups. The four 
compounds showed a favorable drug likeness based on molecular properties.   
 
 
Keywords: Antineoplastic; nitrogen mustard; alkylating; cancer. 
 
ABBREVIATIONS 
  
Term: PC, path coefficient; GPCR, G protein–coupled receptors. 
 
1. INTRODUCTION  
 
Alkylating agents are a class of anticancer drugs 
that directly damage DNA to prevent the cancer 
cell from undergoing division [1]. A rapidly 
dividing cell is most susceptible to the effects of 
alkylating agents, which in their action to produce 
a cross-linking of DNA either intra-strand or inter-
strand [1]. Nitrogen mustard drugs are an 
alkylating agent that can cyclize in an aqueous 
environment to form highly electrophilic 
immonium ions that can covalently bind to the 
nucleophilic N-7 nitrogen position on guanine [1].  
Examples of alkylating agents are busulfan 
(utilized for treating chronic myelogenous 
leukemia), cyclophosphamide (utilized for 
treating non-Hodgkin’s lymphoma, leukemias, 
ovarian cancer, and breast cancer), and 
mechlorethamine (utilized for treating Hodgkin’s 
disease) [1]. Monoalkylating agents can react 
with only one N-7 of a guanine molecule [1].   
 
Classical alkylating agents include melphalan, 
chlorambucil, nitrogen mustards, nitrosoureas, 
and alkyl sulfonates [2,3]. In general, anticancer 
drugs can be classified by the mechanism of 
action, the groups as follows [1]: Alkylating 
agents (damage done during S phase or 
doubling of chromosomal material), heavy metals 
(e.g. platinum agents), antimetabolites, folic acid 
antagonists, pyrimidine analogues, purine 
analogues, cytotoxic antibiotics, spindle poisons 
(e.g. toxoids), and topoisomerase inhibitors.  
Additional clinical studies have shown a revived 
application for alkylating agents. A notable 
example is an improved outcome/treatment 
found with chlorambucil treatment of chronic 
lymphocytic leukemia [4].  The clinical purpose of 
antineoplastic agents is the elimination of cancer 
cells without affecting normal tissue [1].   
 
Alkylating agents can cross link with carboxyl, 
hydroxyl, amino, sulfhydryl, and phosphate 
groups of bio-macromolecules [5]. This action 
cause abnormal base paring or scission of the 
DNA strand [5].  The kill rate of cancer cells can 
be enhanced with intensive/more frequent 
treatment or surgical removal with chemotherapy 
[1].   
 
In the case of alkylating agents targeting DNA at 
physiological pH, the most reactive nucleophilic 
sites are N-7 of guanine > N-3 of adenine > N-1 
of adenine > N-1 of cytosine [5]. Alkylating 
agents such as nitrogen mustards are able to 
undergo either SN1 (unimolecular) or SN2 
(bimolecular) type reactions depending on the 
rate of aziridinium ion (a positive charged ring) 
formation [5].   
 
Further studies of the alkylation agents will 
improve effectiveness and clinical outcome for 
cancer patients. The knowledge of the 
mechanism of action can enhance understanding 
of the type of alkylating antineoplastic agents 
more suitable for specific cancer cases. This 
study presents four novel alkylating agents, with 
the characterization of the kinetics of reaction 
with a targeted nucleophilic amine group.  
 
2. METHODOLOGY  
 
2.1 Chemicals and Instrumentation 
 
Reagents utilized for the study were of HPLC 
grade and obtained from Aldrich Company 
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(Aldrich, PO Box 2060, Milwaukee WI 53201).  
Infrared spectra were obtained from a Mattson 
Galaxy FTIR in dimethyl-sulfoxide that was 
previously dried over molecular sieves.  The 
visible wavelength spectroscopy for kinetics was 
accomplished utilizing Spectronic 21-D 
instrument with glass cuvettes. For controlled 
temperature monitoring of alkylation reaction 
required for rate-order determination a THELCO 
Model 84 controlled water bath was utilized 
(Precision Scientific Company, Chicago Illinois 
60647 USA).  
 
2.2 Software, Programs, and Molecular 
Modeling 
 
The molecular properties of these study 
compounds were determined by utilizing 
Molinspiration informatics (Molinspiration 
Cheminformatics, Nova ulica, SK-900 26 
Slovensky Grob, Slovak Republic), ChemSketch 
version 12.01 (copyright 1994-2009, ACD, 90 
Adelaide Street West, Toronto Ontario, M5H3V9 
Canada), and ALOGPS software [6].   
Calculation of water solubility was completed 
with EPISUITE version 1.66 (Copyright 2000, 
U.S. Environmental Protection Agency, 
Washington DC). Summary statistics was 
performed by PAST Version 0.45 (Copyright 
Oyvind Hammer, 2001) [7] and Microsoft EXCEL 
2013 from Microsoft Office Professional plus 
2013. Bioactivity scores for compounds were 
determined by Molinspiration Cheminformatics.  
For outliers, Grubb’s test was applied              
with online QuickCalcs Graphpad 
(http://www.graphpad.com/quickcalcs/).   
 
2.3 Synthesis of Alkylating Compounds 
 
2.3.1 Synthesis of compound (A) 
 
Place 0.000652 moles (0.0750 grams) of (S)-(-)-
4-oxo-2-azetidine carboxylic acid into 50.0 mL of 
acetone that is previously dried over molecular 
sieves.  Force ammonia (NH3) gas through the 
mixture for 2 hours then degas with nitrogen flow 
to remove the residual ammonia.  Add 20x 
excess by moles of ClCH2CH2Cl and reflux (mild) 
for 1 hour.  Precipitate the product at -10°C 
overnight, then filter out by vacuum filtration.  
Wash with -10°C diethyl ether and the product 
can be store dry at -10°C.  
 
Infrared analysis of Compound (A) : For C-N, 
1350-1000 cm-1; C=O, 1700 cm-1; C-H 3000 cm-1 
(broad); N-H 3300 cm
-1
 (broad); Beta-lactam 
ring-1750 to 1800 cm
-1
 (beta-lactam strained 
ring); Alkyl halogen 720 cm-1 (C-Cl).  For carbon-
13 assignments in sequence (ppm): 22.7, 44.6, 
50.9, 69.5, 172.0, and 174.4. 
 
2.3.2 Synthesis of D-alanine nitrogen 
mustard compound (B) 
 
Place 0.00337 moles (0.300 g) of D-alanine into 
40 mL acetonitrile which has been dried over 
molecular sieves (3 Angstroms). Bubble 
ammonia gas (NH3) through the mixture for 30 
minutes, then degas with nitrogen flow for at 
least 30 minutes to remove residual ammonia.  
Add ½ volume in 1,2-dichloroethane and reflux 
mildly for 2 to 3 hours.  Precipitate product at -
10°C overnight, filter out by vacuum filtration, 
and wash with -10°C diethylether.  Keep dry and 
store over desiccant at -10°C. 
 
Infrared analysis of Compound (B): For ester 
group 1700 cm
-1
 (C=O stretch); C-N 1350-1000 
cm-1; tertiary amine group-1200 cm-1 (C-N 
stretch); Alkyl halogen-720 cm
-1
 (C-Cl); C-H 3000 
cm-1 (broad). For carbon-13 assignments in 
sequence (ppm): 14.9, 44.6, 44.7, 53.1, 59.0, 
69.5, 172.0.  
 
2.3.3 Synthesis of compound (C) 
 
Place 0.00260 moles (0.500 grams) of citric acid 
into 50.0 mL of acetonitrile dried over molecular 
sieves.  Add 2.0 mL of thionyl chloride and reflux 
for 2 hours.  Remove excess thionyl chloride by 
distillation and adding additional acetonitrile to 
maintain volume.  Cool, then add 0.3 mL of 
triethylamine with 0.0156 moles of 
triethanolamine (which has been dissolved in 
minimal dry acetonitrile previously).  Reflux mildly 
for 1 hours.  Precipitate product at -10°C 
overnight, then vacuum filter to isolate product.  
Wash with -10°C diethyl ether, store the ester of 
citric acid dry at -10°C. Then place 0.00130 
moles of ester of citric acid into 50.0 mL of dry 
acetonitrile, followed by 5.0 mL of triethylamine.  
Slowly add 0.00130 moles of thionyl chloride, 
reflux mildly for 1 hour to 2 hours.  Precipitate 
final product at -10°C overnight, then vacuum 
filter out the final product.  Wash with -10°C 
acetone, store dry at -10°C.  
 
Infrared analysis of Compound (C): For ester 
group 1700 cm-1 (C=O stretch); C-H 3000  cm-1 
(broad); C-Cl aliphatic halogen 705 cm
-1 
; tertiary 
amine group 1180 cm
-1
 (C-N stretch); C-N 1350-
1000 cm-1. For carbon-13 assignments in 
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sequence (ppm): 39.3, 44.7, 52.2, 55.1, 55.9, 
66.2, 66.4, 166.4, and 172.0. 
 
2.3.4 Synthesis of octyl methanesulfonate 
compound (D) 
 
Place 0.0312 moles (3.00 grams) of 
methanesulfonic acid into 50 mL of acetonitrile 
dried over molecular sieves (3 Angstroms size of 
sieve).  Add 3 to 5 mL of thionyl chloride into this 
mixture and reflux for 2 to 3 hours.  Distill out 
excess thionyl chloride while adding additional 
acetonitrile to maintain volume.  Add 0.03590 
moles of 1-octanol, 0.1 milliliter of triethylamine, 
and reflux (mild) for 2 to 3 hours.  Distill out 
solvent to reduce volume and precipitate product 
at -10°C overnight. Carefully remove supernatant 
from product and wash several times with -10°C 
diethyl ether, remove ether supernatant wash 
from product by vacuum if necessary. The 
product must be kept dry and store at -10°C until 
use.   
 
Infrared analysis of Compound (D): For 
methanesulfonate group 1350-1300 cm
-1 
(S=O); 
C-O 1300-1000 cm-1 (stretch);  C(S=O)-C 1050 
cm
-1
; (-CH2-O-S-) group- 950 to 1075 cm
-1
; C-H 
3000 cm-1 (broad). For carbon-13 assignments in 
sequence (ppm): 14.0, 23.1, 26.2, 30.0, 30.3, 
30.7, 32.5, 53.9, and 72.4. 
 
2.4 Measurement and Determination of 
Rate-Order and Rate Constants 
 
Fluorescamine solution: A stock solution of 
fluorescamine is made new before each 
spectroscopy determination. This reagent is 
made to a concentration of 5.0 
milligrams/milliliter of methanol. For 25 milliliters, 
dissolve 125 milligrams of fluorescamine into 25 
milliliters of methanol.   
 
Buffer solution with p-chloroaniline: Into a 
previous prepared aqueous pH 7.4, 0.100 molar 
NaHCO3 buffer dissolve one milligram of p-
chloroaniline per milliliter. This mixture should be 
made up fresh prior to use. 
 
Analysis for Rate-Order of Reaction and Rate 
Constant: Pre-warm a volume of 1.00 milliliter of 
aqueous pH 7.4, 0.100 molar NaHCO3 that also 
contains 1.0 milligram of p-chloroaniline. Place 
25.0 milligrams of the alkylating compound to be 
tested into this volume of aqueous buffer and 
keep at 37°C with the water bath. Start time 
monitor upon addition of reactant (alkylating 
compound and p-chloroaniline). At known time 
periods withdraw 50 microliters of reaction 
mixture and place into a glass cuvette, add 50 
microliters of fluorescamine (that is 5 mg/mL in 
methanol), mix well, then add distilled water to 
3.00 milliliters total volume. The mixtures should 
be analyzed by spectrometer quickly, and not 
stored for later use.    
 
Absorbance of mixtures are read at 400 
nanometers wavelength with suitable visible 
wavelength spectrophotometer (Spec 21 with 1 
cm glass cuvettes for this study). To determine 
the best fit for rate-order of kinetics plot the 
absorbance data is considered the dependent 
variable and the time the sample aliquot is 
withdrawn from the reaction solution is the 
independent variable. For first-order considered 
then plot time (independent variable) versus Ln 
(absorbance). For second-order consideration 
then plot 1/absorbance versus time. For zero 
order consideration then plot raw absorbance 
(dependent variable) versus time. 
 
3. RESULTS AND DISCUSSION 
 
Evaluations of the overall clinical cancer 
treatment outcome have concluded that many 
common cancers are not adequately treated by 
present-day chemotherapy [8]. Crucial is the 
need for novel drugs to treat childhood cancers 
and the mechanisms by which the clinical trials 
can be efficiently conducted [9]. Lead 
modification of alkylating agents has been 
consistently shown to be advantageous for this 
class of anticancer drugs, and has led to 
expansion of their clinical application [5]. The 
four compounds presented here demonstrate the 
potential of covalently bonding alkylation groups 
onto known functional molecular scaffolding and 
the measurement of actual alkylating activity to 
include rate-order determination. The four 
alkylating compounds presented in Fig. 1, are 
studied to show alkylation of a primary amine 
nucleophile (p-chloroaniline), determination of 
rate-constants, and molecular properties. 
 
The reaction order for nucleophilic substitution 
depends on the chemical structure of the 
alkylating agent [5]. An alkylation reaction can 
proceed by SN1 or SN2 mechanisms [5,10]. 
 
Compound A begins with 4-oxoazetidine-2-
carboxylic acid that is modified by emplacement 
of –OCH2CH2Cl substituent upon the former 
carboxyl group (-COOH). The result is an agent 
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having one site of alkylation. Following with 
compound B, the resulting structure has 
potentially three sites of alkylation, to include the 
nitrogen mustard group (-N(CH2CH2Cl)2). 
 
Cl
O
O
O
N
H
Cl
O
O
CH3
ClCl
N
Cl
Cl
Cl
Cl
Cl
Cl
N
N
N
O
O
Cl
O
O
O
O
CH3
O
O
S
OCH3
A
B
C
D
 
Fig. 1. Molecular structures of four alkylating 
compounds.  Compound A (2-chloroethyl 4-
oxoazetidine-2-carboxylate) has one potential 
alkylating site; Compound B (2-chloroethyl 2-
[bis(2-chloroethyl)amino]propanoate)  has 
three potential alkylating sites; Compound C 
(1,2,3-({2-[bis(2-
chloroethyl)amino]ethoxy}carbonyl)-2-
chloropropane) has 6 potential alkylating 
sites; and compound D (octyl 
methanesulfonate) has one potential 
alkylating site 
Compound C begins with citric acid (C6H8O7, 2-
hydroxypropane-1, 2, 3-trioic acid) that continues 
to finally having three nitrogen mustard groups 
with a potential of six alkylation sites.  Compound 
D, beginning with 1-octanol, has a single 
methane sulfonate group allowing one alkylation 
site.  
 
The molecular properties of compounds A, B, C, 
and D are shown in Table 1. Various molecular 
properties are known to substantially affect the 
drug-likeness of a compound, the polar surface 
area has been shown to be useful in predicting 
intestinal absorption [11]. Fast and reliable 
estimation of intestinal absorption can be 
achieved by determination of polar surface area 
[11]. Based on polar surface area values for A, B, 
C, and D, the expected level of intestinal 
absorption for drug amount present following oral 
administration would be 89%, 99%, 48%, and 
97%, respectively.   
 
Although substantially different in molecular 
structure, the property numerical values for all 
four compounds given in Fig. 1 have very strong 
positive correlation with Pearson r correlation for 
all four compounds is greater than 0.9900 (very 
strong positive correlation is r > 0.7000).  
 
One-way ANOVA testing of the Table 1 
properties indicates that the mean of the 
summed values are equal (P=0.38) [12]. In 
addition, by the Kruskal-Wallis test there is no 
significant difference between sample medians 
(P= 0.86). An interesting finding for these 
alkylating compounds of different structures.   
 
Following with the Grubb’s test for outliers (alpha 
= 0.05) [12], notably there are no outliers for 
numerical values of formula weight, number of 
oxygen & nitrogen atoms, polar surface area, 
molecular volume, and Log P. The solubility 
indicated in mole per liter has a strong negative 
correlation with a formula weight (Pearson 
correlation r = -0.4505) and molecular volume 
(Pearson correlation r = -0.5005). That is, as 
molecular weight and molecular volume 
increases, the solubility of the compound 
decreases. This is consistent with previous 
studies of drug-likeness where drug solubility in 
general is shown to decrease with increase of 
molecular size [13]. 
 
The Rule of five, also known as the Pfizer's rule 
of five, is a set of parameters to evaluate drug-
likeness and to determine if a chemical 
compound with a certain pharmacological or
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Table 1. Properties of compounds 
 
Property Compound A Compound B Compound C Compound D 
Log P 0.010 2.35 4.21 3.13 
Polar surface area 
(Angstroms2) 
55.40 29.54 88.63 43.38 
Number of atoms 11 15 40 13 
Formula weight 
grams/mole 
177.59 276.59 714.77 208.32 
Number of oxygen & nitrogen 
atoms 
4 3 9 3 
Number of –OH & -NHn 1 0 0 0 
Violations of the rule of 5 0 0 1 0 
Number of rotatable bonds 4 9 29 8 
Molecular volume 
(Angstroms
3
) 
141.92 228.19 582.18 203.79 
Solubility  
(mole/Liter) 
0.295 5.01E-03 6.31E-07 6.17E-04 
 
biological activity has properties that would make 
it a likely orally active drug in humans [14]. In 
general, when considering potentially useful 
compounds for medicinal purposes, then an 
orally active drug has no more than one violation 
of the following criteria [14]: 
 
A. No more than 5 hydrogen bond donors 
(total number of –NHn and -OH) 
B. Not more than 10 hydrogen bond 
acceptors (all nitrogen or oxygen atoms) 
C. A molecular mass less than 500 Daltons 
D. An octanol-water partition coefficient log P 
not greater than 5 
 
Shown in Table 1, compounds A, B, and D has 
zero violations of Rule of 5, while compound C 
has only one violation. Essentially, by this 
criteria, all compounds are considered to have 
suitable oral activity capability. These 
compounds show a favorable drug-likeness. In 
addition, previous studies have shown that orally 
active drugs having polar surface area less than 
120 Angstroms
2
 are suitable for passive 
transport by the transcellular route [15], which is 
a criteria compounds A, B, C, and D fulfill. A drug 
having polar surface area less than 60 
Angstroms
2
 are able to penetrate through the 
brain-blood barrier and into the brain. By this 
criteria, compounds A, B, and D are suitable for 
penetrating into the brain.  
  
It is beneficial to have tools to predict and 
discriminate the pharmacological activity of a 
given molecular compound so that the study is 
directed to molecular groups where there is a 
high probability of finding new compounds with 
desired properties [14,15]. Biological activity or 
pharmacological activity, describes the beneficial 
or adverse effects of a drug on target tissues.  
Generally, an activity is considered to be dose-
dependent and a compound is considered 
bioactive if it has interacted with or effect on a 
target tissue of the human body. By use of 
Bayesian statistics the four compounds were 
compared to six highly important drug classes to 
determine bioactivity scores (see Table 2). With 
respect to drug-likeness for the classes of GPCR 
ligand, ion channel modulator, and kinase 
inhibitor the range of drug-lilke compounds are: -
1.50 to 0.50, -2.0 to 0.5, and -1.8 to 0.5, 
respectively. Note that all four compounds A, B, 
C, and D have scores that fall within the 
prospective ranges for identification as drug-like 
compounds. For the classes of nuclear receptor 
ligand, protease inhibitor, and enzyme inhibitor, 
the criteria range of score for drug-like 
compounds are: -2.0 to 0.5, -1.7 to 0.5, and -1.5 
to 0.5, respectively. Note that all four compounds 
A, B, C, and D have scores that fall within the 
perspective ranges for drug-like compounds.  
These results support the beneficial potential of 
these four compounds. All four compounds have 
bioactivity scores within the drug-like region for 
all six important classes of drugs. The molecular 
structures of the four compounds substantially 
differ. One-way ANOVA analysis of Table 2 
values indicates that the means of the         
scores determined for A, B, C, and D are not 
equal  (P= 0.000139).  
 
For determination of rate-order and rate 
constants of alkylation reactions, the compounds 
were placed into buffered aqueous solutions at 
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physiological pH 7.4 and 37°C. The target of 
alkylation is the nucleophilic amine group (-NH2) 
of p-chloroaniline. An alkylation reaction of p-
chloroaniline with any of the four compounds will 
eliminate the primary amine group. The 
presence, and change in concentration of the 
primary amine group –NH2 can be accurately 
assayed by use of fluorescamine.  
Fluorescamine itself is a spiro compound that 
does not fluorescent itself, but reacts with 
primary amines to form a highly fluorescent 
product. By this means, it has been used as a 
reagent for the detection of amines and peptides 
[16]. The reaction of compound A with p-
chloroaniline is shown in Fig. 2. 
 
In the reaction solutions, after alkylation, there is 
left remaining unreacted p-chloroaniline which 
can be assayed by the highly specific 
fluorescamine derivatization of the primary amine 
group and detection at 400 nm wavelength 
[17,18].  Removing of aliquots at known time and 
assay at 400 nm allows the monitoring of the 
course of the alkylation reaction (by a monitor of 
un-reacted p-chloroaniline).  By this approach the 
elucidation for rate-order of the reaction and the 
rate constants can be determined. Two examples 
of these plots, one for second-order (compound 
A) and one for first-order (compound C) are 
presented in Fig. 3.  
Note that the Pearson correlation coefficient for 
compound A second-order plot, is r = 0.9947 
(extremely high positive correlation). With the 
Pearson correlation coefficient for compound C 
first-order plot being r = 0.9399 (very strong 
positive correlation is r > 0.7000). 
 
The reaction order with rate constants for 
compounds A, B, C, and D are presented in 
Table 3 for comparison to the number of 
alkylation sites, formula weight, polar surface 
area, and Log P.  The Grubb’s test indicated that 
there were no outliers among the numerical 
values of the rate constants.  
 
There is a strong negative relationship of rate 
constants values to polar surface area (Pearson 
r= -0.5027) and to Log P (Pearson r = -0.5149) 
(strong negative correlation is r from -0.4000 to -
0.6900). There is a very strong positive 
relationship of number of alkylation sites to 
formula weight (Pearson r = 0.9672), but strong 
positive relationship to polar surface area 
(Pearson r = 0.6849) and Log P (Pearson r = 
0.6949) (strong positive correlation is r from 
0.4000 to 0.6900). This suggests 
interrelationship of rate of reaction to the 
physiochemical properties of the alkylating 
compounds. 
 
Table 2. Bioactivity scores for compounds 
 
Biological activity Compound A Compound B Compound C Compound C 
GPCR ligand -1.07 -0.80 -0.13 -0.56 
Ion channel modulator -0.79 -0.54 -0.48 -0.66 
Kinase inhibitor -1.37 -0.75 -0.17 -0.95 
Nuclear receptor ligand -1.53 -1.00 -0.13 -0.50 
Protease inhibitor -0.93 -0.70 -0.08 -0.39 
Enzyme inhibitor -0.86 -0.61 -0.015 0.34 
   
Table 3. Rate of reaction and rate constant comparison 
 
Drug Number of 
sites of 
alkylation 
Formula 
weight 
(grams/mole) 
Polar 
surface 
area (A2) 
Log P Reaction order 
rate constant 
Compound A 1 177.59 55.40 0.010 Second order 
0.0184 molar-1 minute-1 
Compound B 3 276.59 29.54 2.35 First order 
0.0258 minute-1 
Compound C 6 714.77 88.63 4.21 First order 
0.00997 minute-1 
Compound D 1 208.32 43.38 3.13 First order 
0.00594 minute
-1
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Fig. 2. Example alkylation reaction of compound A with target p-chloroaniline. The primary 
amine group of p-chloroaniline is eliminated 
 
 
 
Fig. 3. Example plots for rate-order analysis, for compound A (top) and compound C (bottom).  
The pearson correlation coefficient for compound A second-order plot, is 
r = 0.9947 (very strong high positive correlation is r > 0.7000). The pearson correlation 
coefficient for first-order plot of compound C is a very strong positive correlation r = 0.9399 
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Further explanation for the causality of the rate of 
reactions can be determined by use of path 
analysis. Path analysis is an extension of 
multiple regression with the aim to provide 
estimates of the magnitude and significance of 
hypothesized causal connections between sets 
of variables [19]. Path analysis is a form of 
statistical analysis used to evaluate causal 
models by examining the relationships between a 
dependent variable and two or more independent 
variables. There are two main requirements for 
path analysis [19]: 1) All causal relationships 
between variables must go in one direction only 
(i.e. a pair of variables cannot cause each other); 
2). The variables must have a clear time-ordering 
since one variable cannot be said to cause 
another unless it precedes it in time.   
 
Representation of results of path analysis is 
achieved by considering a path diagram, which 
presents the names of the variables and draws 
arrows from each variable to any other variable 
we believe that it affects. Associated with the 
arrows are path coefficients (PC) that are 
standardized versions of linear regression 
weights used to examine the possible causal 
linkage between variables in the modeling 
approach [19,20]. 
 
The rate constants for alkylation reaction of 
compounds A, B, C, and D with a nucleophile is 
shown in Table 3. An interesting inquiry is to 
apply path analysis to elucidate which of the 
important molecular properties formula weight, 
polar surface area, Log P, or number of 
alkylation sites can be identified as causative 
variable(s) for rate of reaction. The larger the 
path coefficient, the greater the proposed 
causative relationship between variables [19,20]. 
 
The path diagram outcome of path analysis of 
Table 3 is presented in Fig. 4. The parameters of 
the path analysis evaluated the causality of each 
property as stand-alone to actual rate constants 
(or the rate of reaction). A striking result is 
observed, and that is the importance of each 
property for the measured rate of reaction.  
Essentially, Log P is found to have great 
influence (PC = 0.629), followed by number of 
alkylation sites (PC = 0.435). These two 
properties exert highest influence, but are 
followed by the formula weight (PC = 0.351) and 
polar surface area (PC = 0.261).  This provides a 
means to understand the rate of alkylation of a 
nucleophile and how that rate is influenced. 
 
The four compounds A, B, C, and D have been 
shown to efficiently alkylate a nucleophilic 
primary amine group. All compounds 
demonstrated favorable drug-likeness and for 
compounds A, B, and D have the favorable 
potential of penetrating through the blood-brain 
barrier, as a consequence of the low polar 
surface area.   
 
 
 
Fig. 4. Path diagrams show variables interconnected and specify causal flow. A path 
coefficient in this model clearly shows that the casual relationship of property to rate constant 
values has the following order: Log P (0.629) > number of alkylation sites (0.435) > formula 
weight (0.351) > polar surface area (0.261) 
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The study, synthesis, and examination of novel 
alkylating agents is a very necessary endeavor in 
the pursuit of useful medicaments for clinical 
treatment of neoplastic diseases. In this study, 
four compounds were formed by emplacement of 
functional groups known to effectuate an 
alkylation reactivity. The requirement for 
successful kinetics analysis is that it is imperative 
to monitor the reaction's progress by following 
the change in concentration for at least one of its 
species. These four compounds are successful 
alkylating agents and have been characterized to 
authenticate the favorable potential as 
antineoplastic drugs.  
 
4. CONCLUSION 
 
Compounds A, B, C, and D were synthesized 
and have one or more alkylating substituents 
covalently bonded to molecular scaffolding 
suitable for drug delivery. Molecular properties 
were determined, finding values of polar surface 
area to be: 55.40 A2, 29.54 A2, 88.63 A2, and 
43.38 A
2
, respectively. These values indicate that 
compounds A, B, and D would penetrate into the 
central nervous system. Examination of various 
molecular properties infers all four compounds 
have a favorable drug-likeness, based on Rule of 
5. From these polar surface area values for A, B, 
C, and D, the anticipated level of intestinal 
absorption for drug amount present following oral 
administration would be 89%, 99%, 48%, and 
97%, respectively. Monitoring the absorbance of 
fluorescamine-drug complex at 400 nm allowed 
determination of rate-order and rate constants for 
alkylation reactions of these compounds. Rate 
constants were determined for alkylation 
reactions and path analysis calculated path 
coefficients to be Log P (0.629), number of 
alkylation sites (0.435), formula weight (0.351), 
and polar surface area (0.0261). Bioactivity 
scores for six classes showed that all 
compounds are classified drug-like.   
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